查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1716771

不孕症治疗市场（按产品类型、治疗类型、诊断方法、最终用户划分）—2025 年至 2030 年全球预测

Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

不孕症治疗市场预计在 2024 年将达到 59.3 亿美元，在 2025 年将达到 65.8 亿美元，到 2030 年将达到 113 亿美元，复合年增长率为 11.32%。

主要市场统计数据
基准年2024年 59.3亿美元
预计2025年 65.8亿美元
预测年份 2030 113亿美元
复合年增长率（%） 11.32%

在医学快速发展的今天，不孕症治疗已经成为无数个人和家庭的一线希望。随着尖端技术创新和患者照护标准的不断提高，这个市场不仅规模不断增长，而且复杂性也在不断演变。在过去的几年里，新技术与对生殖医学的更深入理解相结合，改变了诊断和治疗实践。这种转变体现在微创手术的日益普及、检查技术的优化以及监测工具的增强，这些都显着提高了治疗週期的成功率。

全球对个人化和改善患者体验的关注导致了解决不孕症问题的更全面的方法。医疗保健提供者和研究人员正在不断探索将传统方法与新的科学发现相结合的综合治疗途径，从而提高疗效并减轻患者的心理和经济负担。本执行摘要确定了主要的市场趋势，概述了主要的细分发现，并提供了一系列可行的建议以进一步探索这一充满活力的领域。

重新定义生育治疗的变革性转变

近年来，不孕症治疗的环境发生了巨大变化。诊断影像系统和雷射设备等领域的技术引入为更准确的诊断和有针对性的干预铺平了道路。现代低温系统和先进的培养箱设计彻底改变了保存过程，确保了后续治疗週期的更高成功率。这些进步是由对以患者为中心的护理的日益重视所推动的，临床医生青睐于能够最大程度减少不适并加快恢復时间的技术。

此外，法律规范和增加的研究资金正在加速创新治疗方法的采用。随着新技术融入常规临床实践，我们正在见证向高度专业化的诊断工具和治疗方法的转变。这种转变不仅提高了患者照护的质量，也改变了产业内的竞争态势。决策者现在发现自己正处于拥抱技术进步和确保卓越营运的十字路口，因此他们必须在策略上适应当前的市场需求。

塑造市场的详细细分洞察

对市场的详细评估揭示了清晰的细分模式，推动了不孕症治疗产业的策略决策。根据产品类型，我们专注于配件、设备以及介质和消耗品。具体来说，设备部分对低温系统、气体分析仪、成像系统、培养箱、雷射系统、微操作系统、显微镜、卵子抽吸泵、精子分析仪系统和精子分离器进行了全面而详细的回顾。此外，冷冻保存和培养基等培养基和消耗品在治疗过程中保持高品质和活力方面发挥着至关重要的作用。

根据治疗类型进行细分可以揭示更多见解。市场分析主要关注子宫颈内、子宫内和子宫内方法的人工授精，这些方法已经被特别研究。辅助生殖技术 (ART) 包括胚胎冷冻保存、体外受精 (IVF)、卵细胞质内单一精虫显微注射术(ICSI) 和胚胎着床前基因诊断 (PGD)。同样，不孕症治疗包括针对性不孕症药物，如克罗米芬柠檬酸盐、促性腺激素分泌、来曲唑和Metformin，以及节育手术，如子子宫镜检查、腹腔镜检查、肌瘤切除术、子宫肿块修復术和子宫切除术。进一步基于诊断的细分区分了女性不孕症（透过造影和排卵测试进行评估）和男性不孕症（透过血液检查、精液分析和睪丸切片检查进行评估）之间的细微差别，最终用户包括冷冻库、不孕症诊所、医院和研究机构。这个全面的细分框架为市场理解和策略规划提供了坚实的基础。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 生活型态改变和生育延迟导致不孕不育率上升
      • 增加生育治疗研发的投资和资金
      • 提高对辅助生殖技术的认识与接受度
    • 限制因素
      • 生育治疗费用高昂，且治疗通讯协定多变
    • 机会
      • 推动个人化医疗方法，根据个别患者的生育状况量身定制
      • 引入远端医疗，扩大生育咨询和治疗的机会
    • 任务
      • 缺乏对生育治疗的认识与教育
  • 市场区隔分析
    • 产品类型：设备在生育治疗的重要性日益增加
    • 最终使用者：全面的生育治疗增加了人们对生育诊所的兴趣。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 生育治疗市场（依产品类型）

  • 配件
  • 装置
    • 低温系统
    • 气体分析仪
    • 影像系统
    • 培养箱
    • 雷射系统
    • 微作业系统
    • 显微镜
    • 卵子吸泵
    • 精子分析系统
    • 精子分离器
  • 介质和耗材
    • 冷冻保存培养基
    • 文化传媒

第七章 不孕症治疗市场（依治疗类型）

  • 人工授精
    • 子宫颈内授精
    • 输卵管内授精
    • 子宫腔内授精
  • 辅助生殖技术（ART）
    • 胚胎冷冻保存
    • 体外受精（IVF）
    • 卵细胞质内单一精虫显微注射术（ICSI）
    • 胚胎着床前基因诊断（PGD）
  • 生育药物
    • 克罗米芬柠檬酸盐
    • 促性腺激素分泌
    • 来曲唑
    • Metformin
  • 不孕不育治疗手术
    • 子宫镜检查
    • 腹腔镜检查
    • 子宫肌瘤切除术
    • 静脉曲张修復
    • 静脉曲张切除术

第八章 不孕症治疗市场（依诊断）

  • 女性不孕症
    • 造影（HSG）
    • 排卵测试
  • 男性不孕
    • 血液检查
    • 精子分析
    • 切片检查

第九章不孕症治疗市场（依最终使用者）

  • 精子库
  • 不孕不育诊所
  • 医院
  • 研究机构

第十章美洲的生育治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生育治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲生育治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • Bayer AG
  • City Fertility Centre
  • CooperSurgical, Inc.
  • Cryoport Systems, LLC.
  • Embryolab
  • EQUIPO IVI, SL
  • Ferring International Center SA
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Group
  • IVI AMERICA, LLC
  • Merck KGaA
  • Monash IVF
  • New Hope Fertility Clinic
  • Nova IVF Fertility
  • NOW-fertility SA
  • Ovum Woman and Child specialty Hospital
  • ReproTech LLC
  • Seegene, Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife Sweden AB
Product Code: MRR-3E32260F8122

The Infertility Treatment Market was valued at USD 5.93 billion in 2024 and is projected to grow to USD 6.58 billion in 2025, with a CAGR of 11.32%, reaching USD 11.30 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.93 billion
Estimated Year [2025] USD 6.58 billion
Forecast Year [2030] USD 11.30 billion
CAGR (%) 11.32%

In today's rapidly advancing medical field, infertility treatment has emerged as a beacon of hope for countless individuals and families. The market is not just expanding in terms of size, but also evolving in complexity due to cutting-edge innovations and enhanced patient care standards. Over the past several years, the convergence of new technologies and a deeper understanding of reproductive health has transformed diagnostic and treatment practices. This transformation is evident in the increased adoption of minimally invasive procedures, optimized laboratory techniques, and enhanced monitoring tools that have significantly boosted success rates in treatment cycles.

The global focus on personalization and improved patient experiences has led to a more holistic approach in addressing infertility. Health care providers and researchers are continually exploring integrated treatment pathways that combine traditional methods with novel scientific discoveries, resulting in increased efficacy and reduced emotional as well as financial burdens for patients. As we delve further, this executive summary highlights critical market trends, outlines key segmentation findings, and presents actionable recommendations that collectively bring clarity to this dynamic sector.

Transformative Shifts Redefining Infertility Treatment

Recent years have witnessed transformative shifts that are reshaping the infertility treatment landscape. Technological adoption in areas such as imaging systems and laser equipment has paved the way for more precise diagnostics and targeted interventions. Modern cryosystems and advanced incubator designs have revolutionized the preservation processes, ensuring higher success rates during subsequent treatment cycles. Such advancements have been bolstered by a greater emphasis on patient-centric care, with clinicians favoring techniques that minimize discomfort and shorten recovery times.

Furthermore, regulatory frameworks and increased funding for research have accelerated the adoption of innovative treatment approaches. As emerging technologies integrate into routine clinical practice, there is a visible transition toward highly specialized diagnostic tools and therapies. This shift is not only elevating the quality of patient care but also triggering competitive dynamic changes within the industry. Decision-makers now find themselves at the crossroads of embracing technological evolution while ensuring operational excellence, making it imperative to adapt strategically to the current market demands.

In-depth Segmentation Insights Shaping the Market

A closer assessment of the market reveals clear segmentation patterns that drive strategic decision-making in the infertility treatment industry. When examining the product type, the focus is placed on Accessories, Equipment, and Media & Consumables. Equipment, in particular, has been studied in comprehensive detail, with special attention given to Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. Additionally, Media & Consumables such as Cryopreservation Media and Culture Media play a pivotal role in maintaining high quality and viability during treatment procedures.

Segmentation based on treatment type uncovers further granular insights. The market analysis explores Artificial Insemination with its specifically studied Intracervical, Intratubal, and Intrauterine methods. Assisted Reproductive Technology (ART) is examined through the lenses of Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). Equally, fertility treatments include targeted fertility drugs, comprising Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin, as well as fertility surgeries such as Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy. Further segmentation based on diagnosis distinguishes the subtle differences between Female Infertility, evaluated through Hysterosalpingography and Ovulation Testing, and Male Infertility, assessed with Blood Tests, Semen Analysis, and Testicular Biopsy, while the end user spectrum covers Cryobanks, Fertility Clinics, Hospitals, and Research Institutes. This comprehensive segmentation framework provides a robust basis for market understanding and strategic planning.

Based on Product Type, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. The Media & Consumables is further studied across Cryopreservation Media and Culture Media.

Based on Treatment Type, market is studied across Artificial Insemination, Assisted Reproductive Technology (ART), Fertility Drugs, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology (ART) is further studied across Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). The Fertility Drugs is further studied across Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy.

Based on Diagnosis, market is studied across Female Infertility and Male Infertility. The Female Infertility is further studied across Hysterosalpingography (HSG) and Ovulation Testing. The Male Infertility is further studied across Blood Tests, Semen Analysis, and Testicular Biopsy.

Based on End User, market is studied across Cryobanks, Fertility Clinics, Hospitals, and Research Institutes.

Key Regional Insights Across Diverse Global Markets

The global infertility treatment market is characterized by remarkable regional diversity, with variations in market maturity, technological readiness, and regulatory support across different territories. In the Americas, robust healthcare infrastructures and a strong emphasis on research innovation have led to early adoption of technologies and advanced treatment protocols, facilitating enhanced patient outcomes. Across Europe, Middle East & Africa, a blend of legacy medical practices and modern breakthroughs creates an ecosystem that values both traditional empathy and high-end technological contributions to infertility care.

In the Asia-Pacific region, accelerated economic development and increasing awareness of reproductive health issues have spurred significant investments in state-of-the-art facilities and treatment centers. This region is witnessing not only rapid growth in patient numbers but also the emergence of local players who are keen to implement innovative methodologies. These regional insights emphasize the importance of localized strategies that consider cultural nuances, economic variables, and infrastructural variations, enabling market players to tailor their offerings and optimize operational effectiveness on both a macro and micro level across the global landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

The competitive dynamics in the infertility treatment market are defined by the presence of several leading and influential companies that drive innovation and set industry benchmarks. Major players such as AbbVie Inc. and Bayer AG are forging ahead by investing in research and development, helping to pioneer cutting-edge treatment methodologies. Specialized institutions like City Fertility Centre and CooperSurgical, Inc. provide customized solutions that cater to diverse patient needs and clinical requirements. Innovative firms such as Cryoport Systems, LLC. and Embryolab, along with EQUIPO IVI, S. L., are continuously refining technologies that enhance operational efficiency and treatment accuracy.

Ferring International Center S.A. and FUJIFILM Irvine Scientific, Inc. further contribute to the competitive landscape with robust portfolios that encompass state-of-the-art equipment and consumables. Companies including Genea Group, IVI AMERICA, LLC, and Merck KGaA have established themselves as thought leaders by integrating advanced research into clinical applications. Notably, specialized clinics and institutes like Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, and NOW-fertility SA, along with dedicated healthcare providers such as Ovum Woman and Child Specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB, continue to shape the market intricately through comprehensive, patient-focused solutions. Their contributions not only drive innovation but also set a high standard for clinical excellence and service delivery.

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, City Fertility Centre, CooperSurgical, Inc., Cryoport Systems, LLC., Embryolab, EQUIPO IVI, S. L., Ferring International Center S.A., FUJIFILM Irvine Scientific, Inc., Genea Group, IVI AMERICA, LLC, Merck KGaA, Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, NOW-fertility SA, Ovum Woman and Child specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB. Actionable Recommendations for Industry Leaders

For industry leaders navigating the challenging but promising infertility treatment landscape, several key recommendations emerge from the analysis. First, continually invest in research and development initiatives to keep pace with advancing technologies and evolving clinical methods. Emphasis should be placed on integrating comprehensive diagnostic systems and ensuring that treatment processes remain patient-centric. Leaders are encouraged to form strategic alliances with technology providers and research institutions as a way to harness cutting-edge innovations while mitigating risks associated with rapid technological changes.

It is crucial to adopt a multi-faceted market approach that considers diverse segmentation factors-from product types and treatment modalities to diagnostic tools and end user needs. Firms should undertake regular competitive benchmarking to align their portfolios with global best practices, while also adapting to regional market dynamics. Enhancing regulatory compliance and focusing on operational efficiency will serve as catalysts for sustained growth. By proactively addressing new market challenges and capitalizing on emerging opportunities, industry leaders can solidify their position and drive long-term value in this evolving sector.

Conclusion and Future Outlook for Infertility Treatment

In conclusion, the infertility treatment market is undergoing a period of significant transformation. The interplay of innovative technologies, targeted segmentation strategies, and rapid regional growth presents abundant opportunities and challenges alike. As advancements in diagnostic and treatment methods continue to evolve, stakeholders must maintain agility and adaptability in order to remain competitive. The depth of segmentation based on product type, treatment type, diagnosis, and end user affirm the complexity of the market, while also highlighting key areas for strategic focus and growth.

Looking forward, an integrated approach that combines technological innovation with strategic market positioning is critical. Insights derived from both regional trends and competitive analyses offer invaluable guidance for shaping the future trajectory of infertility treatment. By embracing new methodologies and fostering collaborative partnerships, the industry can continue to enhance patient outcomes, improve technological adoption, and ultimately deliver more effective and comprehensive care solutions. The roadmap outlined herein serves as a foundation for sustained progress and market leadership in the evolving global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of infertility due to lifestyle changes and delayed parenthood
      • 5.1.1.2. Rising investments and funding in infertility treatment research and development
      • 5.1.1.3. Increasing awareness and acceptance of assisted reproductive technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with infertility treatments and variability in infertility treatment protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement of personalized medicine approaches tailored to individual patient fertility profiles
      • 5.1.3.2. Telemedicine implementation to expand infertility consultations and treatment accessibility
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and education about infertility treatment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising significance of equipment in infertility treatment
    • 5.2.2. End User: Growing preference for fertility clinics due to its comprehensive range of infertility treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infertility Treatment Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
    • 6.3.1. Cryosystems
    • 6.3.2. Gas Analyzers
    • 6.3.3. Imaging Systems
    • 6.3.4. Incubators
    • 6.3.5. Laser Systems
    • 6.3.6. Micromanipulator Systems
    • 6.3.7. Microscopes
    • 6.3.8. Ovum Aspiration Pumps
    • 6.3.9. Sperm Analyzer Systems
    • 6.3.10. Sperm Separation Devices
  • 6.4. Media & Consumables
    • 6.4.1. Cryopreservation Media
    • 6.4.2. Culture Media

7. Infertility Treatment Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Artificial Insemination
    • 7.2.1. Intracervical Insemination
    • 7.2.2. Intratubal Insemination
    • 7.2.3. Intrauterine Insemination
  • 7.3. Assisted Reproductive Technology (ART)
    • 7.3.1. Embryo Cryopreservation
    • 7.3.2. In Vitro Fertilization (IVF)
    • 7.3.3. Intracytoplasmic Sperm Injection (ICSI)
    • 7.3.4. Preimplantation Genetic Diagnosis (PGD)
  • 7.4. Fertility Drugs
    • 7.4.1. Clomiphene Citrate
    • 7.4.2. Gonadotropins
    • 7.4.3. Letrozole
    • 7.4.4. Metformin
  • 7.5. Fertility Surgeries
    • 7.5.1. Hysteroscopy
    • 7.5.2. Laparoscopy
    • 7.5.3. Myomectomy
    • 7.5.4. Varicocele Repair
    • 7.5.5. Varicocelectomy

8. Infertility Treatment Market, by Diagnosis

  • 8.1. Introduction
  • 8.2. Female Infertility
    • 8.2.1. Hysterosalpingography (HSG)
    • 8.2.2. Ovulation Testing
  • 8.3. Male Infertility
    • 8.3.1. Blood Tests
    • 8.3.2. Semen Analysis
    • 8.3.3. Testicular Biopsy

9. Infertility Treatment Market, by End User

  • 9.1. Introduction
  • 9.2. Cryobanks
  • 9.3. Fertility Clinics
  • 9.4. Hospitals
  • 9.5. Research Institutes

10. Americas Infertility Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Infertility Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bayer enters digital health collaboration with Impli to innovate infertility treatment
    • 13.3.2. Birla Fertility's key acquisition of IVF chain BabyScience signifies a robust expansion in India's growing infertility treatment sector
    • 13.3.3. Conduit Pharmaceuticals boosts portfolio with AstraZeneca's assets to tackle autoimmune disorders and infertility
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Bayer AG
  • 3. City Fertility Centre
  • 4. CooperSurgical, Inc.
  • 5. Cryoport Systems, LLC.
  • 6. Embryolab
  • 7. EQUIPO IVI, S. L.
  • 8. Ferring International Center S.A.
  • 9. FUJIFILM Irvine Scientific, Inc.
  • 10. Genea Group
  • 11. IVI AMERICA, LLC
  • 12. Merck KGaA
  • 13. Monash IVF
  • 14. New Hope Fertility Clinic
  • 15. Nova IVF Fertility
  • 16. NOW-fertility SA
  • 17. Ovum Woman and Child specialty Hospital
  • 18. ReproTech LLC
  • 19. Seegene, Inc.
  • 20. TMRW Life Sciences, Inc.
  • 21. Vitrolife Sweden AB

LIST OF FIGURES

  • FIGURE 1. INFERTILITY TREATMENT MARKET MULTI-CURRENCY
  • FIGURE 2. INFERTILITY TREATMENT MARKET MULTI-LANGUAGE
  • FIGURE 3. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 4. INFERTILITY TREATMENT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION (IVF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS (PGD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY METFORMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY (HSG), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TESTICULAR BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 108. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 170. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 182. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 265. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 266. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 267. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 268. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 275. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 277. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 278. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 279. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 280. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 281. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 287. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 289. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 290. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 291. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 292. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 293. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 294. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 312. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 314. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 315. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 316. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 317. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 318. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 319. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 320. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-